Verzenios
*Company:
Eli Lilly and Company (Ireland) LimitedStatus:
No Recent UpdateLegal Category:
Product subject to restricted prescription (C)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 28 August 2024
File name
VERZENIOS SmPC_VE045_JUL24_IE-MT-NI clean.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category:Product subject to restricted prescription (C)
Updated on 04 July 2024
File name
Verzenios_PIL_JUN24_VE040_IE-MT-NI.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 04 July 2024
File name
VERZENIOS SmPC_VE039_JUN24_IE-MT-NI.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to restricted prescription (C)
Free text change information supplied by the pharmaceutical company
Addition of Photopsia
Updated on 21 June 2024
File name
VERZENIOS SmPC_VE037_JUN24_IE-MT-NI.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to restricted prescription (C)
Updated on 21 June 2024
File name
Verzenios_PIL_JUN24_VE038_IE-MT-NI.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 07 March 2024
File name
VERZENIOS SmPC_VE033_NOV23_IE-MT-NI.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to restricted prescription (C)
Updated on 07 March 2024
File name
Verzenios_PIL_NOV23_VE034_IE-MT-NI.pdf
Reasons for updating
- New PIL for new product